期刊文献+

结直肠癌C-erbB-2表达与临床病理的关系及意义 被引量:3

Clinicopathological Significance of C-erbB-2 Protein Expression in Colorectal Carcinoma
下载PDF
导出
摘要 目的探讨结直肠癌C-erbB-2表达与临床病理的关系及临床意义。方法应用免疫组织化学SP法对67例结直肠癌患者的癌组织及正常组织分别行C-erbB-2检测,结果与临床病理指标进行综合分析。结果 C-erbB-2在癌组织中的阳性表达率高于正常结直肠组织(P=0.007)。癌组织中C-erbB-2的表达与性别、肿瘤大小、生长部位、大体分型、组织学类型等临床病理指标均无关(均P〉0.05)。但与Broder分级、淋巴转移、TNM分期有关(均P〈0.05)。C-erbB-2的表达量不同年龄组患者比较,〈30岁组高于〉60岁组(P=0.000),30~60岁患者同样高于〉60岁组(P=0.005)。结论 C-erbB-2表达与结直肠癌的发生、转移有密切关系,可为结直肠癌靶向治疗提供指导。 Objective To investigate the clinicopathological significance of C-erbB-2 protein expression in colorectal carcinoma.Methods Immunohistochemistry(SP method) was used to detect the expression of C-erbB-2 protein in colorectal carcinoma and adjacent tissues of 67 patients,and the relationship of C-erbB-2 protein expression with the clinicopathological parameters of colorectal carcinoma was analyzed.Results C-erbB-2 protein expression in colorectal carcinoma tissue was higher than that in normal colorectal tissue(P=0.007),and it was not correlated with sex,tumor size,tumor sites,general classification,and histologic type(all P0.05).However,C-erbB-2 protein expression significantly increased with more lymphonode metastasis,lower Broder grade,and later TNM stage(all P0.05).The expression of C-erbB-2 protein in patients under the age of 30 years was higher than that in patients older than 60 years of age(P=0.000).In addition,the expression in patients between the ages of 30 and 60 years was also higher than that in patients older than 60 years of age(P=0.005).Conclusion There is a correlation between the expression of C-erbB-2 protein and the genesis and metastasis of colorectal cancer,it can provide guidance for targeted therapy of colorectal carcinoma.
出处 《南昌大学学报(医学版)》 CAS 2010年第7期38-41,共4页 Journal of Nanchang University:Medical Sciences
关键词 结直肠肿瘤 基因 C-erbB-2 临床病理 colorectal tumor gene C-erbB-2 clinical pathology
  • 相关文献

参考文献10

二级参考文献83

共引文献60

同被引文献34

  • 1王锡明,武乐斌,张云亭,柳澄.结肠癌64层螺旋CT增强表现及其病理对照研究[J].实用放射学杂志,2006,22(12):1459-1462. 被引量:22
  • 2薄挽澜,胡凤丽,翟博,姜爱民.c-erbB-2、bcl-2和p53在结直肠肿瘤中的表达及其临床意义[J].胃肠病学,2007,12(5):279-282. 被引量:6
  • 3Fedi P, Pierce JP, Fiore D, et al. Efficient coupling with phosphati- dylinositol 3 - kinase, but not phospholipase C gamma or GTPase - activating protein, distinguishes ErbB - 3 signaling from that of oth- er ErbB/EGFR family members[ J]. Mol Cell Bid, 1994,14 ( 1 ) : 492 - 500.
  • 4Yoo JY, Wang XW, Rishi AK, et al. Interaction of the PA2G4 ( EBP1 ) protein with ErbB - 3 and regulation of this binding by heregulin[ J]. Br J Cancer,2000,82 (3) :683 -690.
  • 5Disis ML, Schiffman K. Caner vaccines taigeting the HER2 onco- gene [ J ]. Semin 0ncol,2001,8 ( 1 ) : 11 - 31.
  • 6Hayes DF,Thor AD. C - erbB - 2 in breast cancer: development of a clinically useful marker [ J 1. Semin Oncol, 2002,29 ( 3 ) : 231 - 245.
  • 7Serrano Olvera A, Duenas Gonzalez A. Gallardo Rincon prognostic, predictive and therapeutic implications of HER2 in invasive epithe- lial ovarian cancer [ J ]. Cancer Treat Rev, 2006,32 ( 3 ) : 180 - 190.
  • 8Lu Y,Zhou H, Chen W. The ErbB -3 binding protein Ebpl regu- lates ErbB - 2 protein levels and tamoxifen sensitivity in breast cancer cells[J]. Breast Cancer Res Treat,2011,126(N1 ):27 - 36.
  • 9Zhang Y, Ali TZ, Zhou H. ErbB - 3 binding protein 1 represses metastasis - promoting gene anterior gradient protein 2 in prostate cancer[ J]. Cancer Res ,2010,70 ( 1 ) :240 - 248.
  • 10Yu Y, Chen W, Zhang Y. Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB -3 binding protein Ebpl gene transfer [ J ]. Int J Cancer, 2007, 120 ( 9 ) : 1909 - 1913.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部